14May
Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By:
Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/
Related
[co-author: Juan Huertas] Even as the world gradually eases out of lockdown, deals are rekindled an...
Read More >
On July 2, 2019, the U.S. Court of Appeals for the Second Circuit handed a significant victory to Ne...
Read More >
The New York State Department of Labor, after holding multiple hearings across the state regarding t...
Read More >
The definition earnings before interest, taxes, depreciation and amortization (“EBITDA”) and adjus...
Read More >
California Assembly Bill 5 has been branded as the killer of the gig economy. It adds to the Califor...
Read More >
With the eyes of Capitol Hill squarely focused on the Senate impeachment proceedings, we turn this w...
Read More >